| CXHB2100042 | BPI-23314片 | BPI-23314 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-03-11 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2022-01-27 | view |
| CXHB2100041 | BPI-23314片 | BPI-23314 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-03-11 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2022-01-27 | view |
| CXHS1500015 | 苯丁酸钠片 | sodium phenylbutyrate | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-05-05 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2021-04-20 | view |
| CXHS2100009 | 甲磺酸贝福替尼胶囊 | Befotertinib Mesylate | Capsule | Chemical Drugs(1) | New Drug Application | 2021-03-04 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2021-03-03 | view |
| CXHS2100008 | 甲磺酸贝福替尼胶囊 | Befotertinib Mesylate | Capsule | Chemical Drugs(1) | New Drug Application | 2021-03-04 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2021-03-03 | view |
| CXHL2100047 | BPI-421286胶囊 | BPI-421286 | Capsule | Chemical Drugs(1) | New Drug Application | 2021-01-22 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2021-01-21 | view |
| CXHL2100046 | BPI-421286胶囊 | BPI-421286 | Capsule | Chemical Drugs(1) | New Drug Application | 2021-01-22 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2021-01-21 | view |
| CXSL2100011 | MCLA-129注射液 | MCLA-129 | Injection | Biological Products(1) | New Drug Application | 2021-01-09 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2021-01-08 | view |
| CXHL2000654 | BPI-21668片 | BPI-21668 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-12-24 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2020-12-23 | view |
| CXHL2000655 | BPI-21668片 | BPI-21668 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-12-24 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2020-12-23 | view |
| CXHL2000650 | BPI-361175片 | BPI-361175 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-12-23 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2020-12-21 | view |
| CXHL2000651 | BPI-361175片 | BPI-361175 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-12-23 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2020-12-21 | view |
| CXHS1800045 | 盐酸恩莎替尼胶囊 | Ensartinib Hydrochloride | Capsule | Chemical Drugs(1) | New Drug Application | 2019-01-02 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2020-11-24 | view |
| CXHS1800046 | 盐酸恩莎替尼胶囊 | Ensartinib Hydrochloride | Capsule | Chemical Drugs(1) | New Drug Application | 2019-01-02 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | Certificate Issued | 2020-11-24 | view |
| CXHL2000565 | BPI-23314片 | BPI-23314 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-11-11 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2020-11-10 | view |
| CXHS2000030 | 盐酸埃克替尼片 | Icotinib | Tablet | Chemical Drugs(2.4) | New Drug Application | 2020-09-24 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2020-09-23 | view |
| CYHS1201557 | 注射用埃索美拉唑钠 | esomeprazole sodium | Lyophilized | Chemical Drugs(6) | Generic Drug | 2013-05-21 | 浙江贝得药业有限公司 | Zhejiang BETTER Pharmaceuticals Co Ltd | Certificate Issued | 2020-06-04 | view |
| CYHB1950083 | 克拉霉素片 | clarithromycin | Tablet | Chemical Drugs | Supplementary Application | 2019-01-21 | 浙江贝得药业有限公司 | Zhejiang BETTER Pharmaceuticals Co Ltd | Certificate Issued | 2020-04-10 | view |
| CXHL2000066 | BPI-28592片 | BPI-28592 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-02-22 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2020-02-21 | view |
| CXHL2000065 | BPI-28592片 | BPI-28592 | Tablet | Chemical Drugs(1) | New Drug Application | 2020-02-22 | 贝达药业股份有限公司 | Betta Pharmaceuticals Co Ltd | In Review | 2020-02-21 | view |
